Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs MasTec Inc (MTZ) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
MasTec IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs MasTec Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while MasTec Inc trades at $191.47 (market cap $16.55B). The key difference: MasTec Inc is far larger — about 4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and MasTec Inc for 25 Days on average.

INDVMTZ
Market Cap
$4.18B$16.55B
Volume
1,819,7461,530,865
Sector
HealthIndustrials
52-Week High
$41.83$437.51
52-Week Low
$24.09$190.08
Typical Hold Time
0 Days25 Days
Enterprise Value
$4.47B$19.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

MasTec Inc

MasTec (MTZ) trades at $206.12, down 0.35% on the day, with technical indicators showing bearish momentum below key moving averages. The company reported strong revenue growth from $14.3B in 2025 to $16.1B in 2026, with net income improving to $494M. Recent news highlights MTZ's record $21.4B backlog and positioning in AI infrastructure and power delivery markets, though cash flow volatility and premium valuation pose challenges.

Wall Street maintains strong bullish sentiment with 89% buy ratings and a $403.92 consensus price target, representing 96% upside potential. Key opportunities include infrastructure investment cycles and data center expansion, while risks include execution challenges, communications segment softness, and elevated P/E ratio of 32.8x.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
MTZ
17% Buy83% Sell
Avg holding period · 25 Days

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ →